We are live on
!
Find out more
ETC
Exchange Traded Concepts Portfolio holdings
AUM
$21.9B
1-Year Est. Return
68.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
–
AUM
$4.06B
AUM Growth
+$411M
(+11%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
1,420
New
288
Increased
397
Reduced
560
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
+$159M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$137M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$125M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$95.4M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$69.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$730M |
| 2 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$487M |
| 3 |
NVIDIA
NVDA
|
+$30.3M |
| 4 |
Verizon
VZ
|
+$19.7M |
| 5 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.96% |
| 2 | Energy | 10.24% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 5.84% |
| 5 | Consumer Discretionary | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Nuvation Bio
NUVB
$2.28B
| $144K | ﹤0.01% |
+79,856
| New | +$136K |
|
|
VECT
852
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $144K | ﹤0.01% |
+8,512
| New | +$112K |
|
853
CBIZ
CBZ
$2.5B
| $143K | ﹤0.01% |
+2,693
| New | +$139K |
|
854
Select Water Solutions
WTTR
$2.25B
| $143K | ﹤0.01% |
+17,653
| New | +$133K |
|
855
Zymeworks
ZYME
$1.66B
| $143K | ﹤0.01% |
+16,528
| New | +$148K |
|
|
MRUS
856
DELISTED
Merus
MRUS
| $143K | ﹤0.01% |
+5,419
| New | +$119K |
|
857
Wells Fargo
WFC
$263B
| $142K | ﹤0.01% |
3,330
-450
| -12% | -$18.1K |
|
858
Arcus Biosciences
RCUS
$3.37B
| $142K | ﹤0.01% |
+6,975
| New | +$133K |
|
859
Enliven Therapeutics
ELVN
$3.79B
| $142K | ﹤0.01% |
+6,934
| New | +$140K |
|
860
Deckers Outdoor
DECK
$14.1B
| $141K | ﹤0.01% |
1,608
-696
| -30% | -$56K |
|
861
Aura Biosciences
AURA
$729M
| $141K | ﹤0.01% |
+11,426
| New | +$122K |
|
862
Genmab
GMAB
$17.9B
| $140K | ﹤0.01% |
+3,696
| New | +$147K |
|
863
Geron
GERN
$937M
| $140K | ﹤0.01% |
+43,602
| New | +$124K |
|
|
EQRX
864
DELISTED
EQRx, Inc. Common Stock
EQRX
| $139K | ﹤0.01% |
+74,812
| New | +$134K |
|
865
Lyell Immunopharma
LYEL
$318M
| $139K | ﹤0.01% |
+2,187
| New | +$121K |
|
|
DCPH
866
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $138K | ﹤0.01% |
+9,803
| New | +$140K |
|
|
THRX
867
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $138K | ﹤0.01% |
+14,791
| New | +$146K |
|
868
Compass Therapeutics
CMPX
$360M
| $137K | ﹤0.01% |
+43,205
| New | +$136K |
|
|
NUVL
869
DELISTED
Nuvalent
NUVL
| $137K | ﹤0.01% |
+3,249
| New | +$123K |
|
870
Replimune Group
REPL
$450M
| $137K | ﹤0.01% |
+5,898
| New | +$115K |
|
871
Immatics
IMTX
$1.14B
| $136K | ﹤0.01% |
+11,816
| New | +$110K |
|
872
Ginkgo Bioworks
DNA
$497M
| $136K | ﹤0.01% |
+1,832
| New | +$108K |
|
873
Best Buy
BBY
$18.8B
| $136K | ﹤0.01% |
1,658
-32,541
| -95% | -$2.43M |
|
|
RAIN
874
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $135K | ﹤0.01% |
+112,812
| New | +$564K |
|
|
MRTX
875
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $135K | ﹤0.01% |
+3,737
| New | +$154K |
|
Similar funds
DSA
IC
AM
BA
AA
MMH
Exchange Traded Concepts's Q2 2023 Portfolio in Review
As of Q2 2023, Exchange Traded Concepts held 1,420 positions worth $4.06B, up 11% from $3.65B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Exchange Traded Concepts deployed $205M of net new capital in Q2 2023, opening 288 new positions and adding to 397 existing holdings. Its largest new stake was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $730M trimmed.
- Exchange Traded Concepts's largest Q2 2023 buy was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.
- Exchange Traded Concepts added most to Vanguard Long-Term Treasury ETF in Q2 2023, an estimated $69.8M increase.
- Exchange Traded Concepts's biggest Q2 2023 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $730M.
- Exchange Traded Concepts fully exited Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2023, selling an estimated $487M.
- Exchange Traded Concepts's ten largest holdings make up 22% of its $4.06B portfolio in Q2 2023.
- Exchange Traded Concepts opened 288 new positions and closed 115 in Q2 2023.
- Exchange Traded Concepts's portfolio value rose 11% quarter-over-quarter to $4.06B.
Based on Exchange Traded Concepts's 13F filing for Q2 2023, filed 20 Jul 2023.